| Property | Value |
|---|
|
?:abstract
|
-
OBJECTIVES In response to the coronavirus disease 2019 (COVID-19) pandemic, many industries, including pharmacy, rapidly expanded the use of telecommuting workers to assure business continuity and address social distancing needs. The purpose of this commentary is to identify potential benefits of telecommuting in pharmacy practice and provide implementation recommendations for its use in pharmacy practice. SUMMARY Advances in electronic health records and telepharmacy over the past 2 decades enabled pharmacy leaders to easily adapt their practice models to allow for telecommuting alternatives during the pandemic. While these changes were generally intended to be part of the short-term response, the sustained expansion of telecommuting within the pharmacy profession merits further exploration. Documented experience with telepharmacy and telehealth indicate a wide array of clinical and operational pharmacist activities that could be conducted by telecommuters. In addition, experience with telecommuters in other industries suggests potential benefits ranging from improving pharmacists\' work-life balance to mitigating postpandemic financial burden. CONCLUSION Healthcare organizations should consider integrating part-time telecommuter pharmacists into contemporary practice models to address other frontline issues and facilitate ongoing expansion of clinical pharmacy services to meet emerging patient needs.
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
-
10.1016/j.japh.2020.07.026
|
|
?:journal
|
-
Journal_of_the_American_Pharmacists_Association_:_JAPhA
|
|
?:license
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
-
Leveraging telecommuting pharmacists in the post-COVID-19 world.
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}